United States · FDA National Drug Code directory
Ebanga
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71655-578_58f2d4af-2a78-c5f5-e063-6294a90a36bb
- Product NDC
- 71655-578
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Ansuvimab
- Labeler
- Emergent BioDefense Operations Lansing LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20201221
- Source listing expiry
- 20271231
Source-listed ingredients
- ANSUVIMAB — 400 mg/8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTON in 1 BOX (71655-578-03) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01) · 71655-578-03
- 4 CARTON in 1 BOX (71655-578-04) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01) · 71655-578-04
- 8 CARTON in 1 BOX (71655-578-08) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01) · 71655-578-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →